Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 204

    1.

    Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial.

    Seibold JR, Korn JH, Simms R, Clements PJ, Moreland LW, Mayes MD, Furst DE, Rothfield N, Steen V, Weisman M, Collier D, Wigley FM, Merkel PA, Csuka ME, Hsu V, Rocco S, Erikson M, Hannigan J, Harkonen WS, Sanders ME.

    Ann Intern Med. 2000 Jun 6;132(11):871-9.PMID: 10836913 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial.

    Khanna D, Clements PJ, Furst DE, Korn JH, Ellman M, Rothfield N, Wigley FM, Moreland LW, Silver R, Kim YH, Steen VD, Firestein GS, Kavanaugh AF, Weisman M, Mayes MD, Collier D, Csuka ME, Simms R, Merkel PA, Medsger TA Jr, Sanders ME, Maranian P, Seibold JR; Relaxin Investigators and the Scleroderma Clinical Trials Consortium.

    Arthritis Rheum. 2009 Apr;60(4):1102-11.PMID: 19333948 [PubMed - indexed for MEDLINE]Related articles

    3.

    Safety and pharmacokinetics of recombinant human relaxin in systemic sclerosis.

    Seibold JR, Clements PJ, Furst DE, Mayes MD, McCloskey DA, Moreland LW, White B, Wigley FM, Rocco S, Erikson M, Hannigan JF, Sanders ME, Amento EP.

    J Rheumatol. 1998 Feb;25(2):302-7.PMID: 9489823 [PubMed - indexed for MEDLINE]Related articles

    4.

    A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma.

    Pope JE, Bellamy N, Seibold JR, Baron M, Ellman M, Carette S, Smith CD, Chalmers IM, Hong P, O'Hanlon D, Kaminska E, Markland J, Sibley J, Catoggio L, Furst DE.

    Arthritis Rheum. 2001 Jun;44(6):1351-8.PMID: 11407694 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trial.

    Khanna D, Furst DE, Clements PJ, Park GS, Hays RD, Yoon J, Korn JH, Merkel PA, Rothfield N, Wigley FM, Moreland LW, Silver R, Steen VD, Weisman M, Mayes MD, Collier DH, Medsger TA Jr, Seibold JR; Relaxin Study Group; Scleroderma Clinical Trials Consortium.

    J Rheumatol. 2005 May;32(5):832-40.PMID: 15868618 [PubMed - indexed for MEDLINE]Related articles

    7.

    Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: a multicenter, placebo-controlled, double-blind study.

    Wigley FM, Korn JH, Csuka ME, Medsger TA Jr, Rothfield NF, Ellman M, Martin R, Collier DH, Weinstein A, Furst DE, Jimenez SA, Mayes MD, Merkel PA, Gruber B, Kaufman L, Varga J, Bell P, Kern J, Marrott P, White B, Simms RW, Phillips AC, Seibold JR.

    Arthritis Rheum. 1998 Apr;41(4):670-7.PMID: 9550476 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    A randomized, blinded, parallel group, placebo controlled pilot study evaluating the effect of PVAC treatment in patients with diffuse systemic sclerosis.

    Genovese MC, Chakravarty EF, Boyle DL, Tutuncu Z, Thorburn CM, Halilhodzic M, Kroll S, Baughman J, Stewart S, Kavanaugh A.

    J Rheumatol. 2005 Dec;32(12):2345-50.PMID: 16331761 [PubMed - indexed for MEDLINE]Related articles

    10.

    Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study.

    Teerlink JR, Metra M, Felker GM, Ponikowski P, Voors AA, Weatherley BD, Marmor A, Katz A, Grzybowski J, Unemori E, Teichman SL, Cotter G.

    Lancet. 2009 Apr 25;373(9673):1429-39. Epub 2009 Mar 28.PMID: 19329178 [PubMed - indexed for MEDLINE]Related articles

    11.

    Interferon-alpha does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized, double-blind, placebo-controlled trial.

    Black CM, Silman AJ, Herrick AI, Denton CP, Wilson H, Newman J, Pompon L, Shi-Wen X.

    Arthritis Rheum. 1999 Feb;42(2):299-305.PMID: 10025924 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Course of the modified Rodnan skin thickness score in systemic sclerosis clinical trials: analysis of three large multicenter, double-blind, randomized controlled trials.

    Amjadi S, Maranian P, Furst DE, Clements PJ, Wong WK, Postlethwaite AE, Khanna PP, Khanna D; Investigators of the D-Penicillamine, Human Recombinant Relaxin, and Oral Bovine Type I Collagen Clinical Trials.

    Arthritis Rheum. 2009 Aug;60(8):2490-8.PMID: 19644851 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma.

    Hoyles RK, Ellis RW, Wellsbury J, Lees B, Newlands P, Goh NS, Roberts C, Desai S, Herrick AL, McHugh NJ, Foley NM, Pearson SB, Emery P, Veale DJ, Denton CP, Wells AU, Black CM, du Bois RM.

    Arthritis Rheum. 2006 Dec;54(12):3962-70.PMID: 17133610 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease.

    Oudiz RJ, Schilz RJ, Barst RJ, Galié N, Rich S, Rubin LJ, Simonneau G; Treprostinil Study Group.

    Chest. 2004 Aug;126(2):420-7.PMID: 15302727 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Comparison of aminobenzoate potassium and placebo in the treatment of scleroderma.

    Clegg DO, Reading JC, Mayes MD, Seibold JR, Harris C, Wigley FM, Ward JR, Pisko EJ, Weisman MH, Lee P, et al.

    J Rheumatol. 1994 Jan;21(1):105-10.PMID: 8151563 [PubMed - indexed for MEDLINE]Related articles

    17.

    Recombinant variant of ciliary neurotrophic factor for weight loss in obese adults: a randomized, dose-ranging study.

    Ettinger MP, Littlejohn TW, Schwartz SL, Weiss SR, McIlwain HH, Heymsfield SB, Bray GA, Roberts WG, Heyman ER, Stambler N, Heshka S, Vicary C, Guler HP.

    JAMA. 2003 Apr 9;289(14):1826-32.PMID: 12684362 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Oral iloprost in Raynaud's phenomenon secondary to systemic sclerosis: a multicentre, placebo-controlled, dose-comparison study.

    Black CM, Halkier-Sørensen L, Belch JJ, Ullman S, Madhok R, Smit AJ, Banga JD, Watson HR.

    Br J Rheumatol. 1998 Sep;37(9):952-60.PMID: 9783759 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

    Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

    Clin Ther. 2008 Aug;30(8):1448-60. Erratum in: Clin Ther. 2008 Oct;30(10):1937. PMID: 18803987 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data